Literature DB >> 16510270

Primary porcine proximal tubular cells as a model for transepithelial drug transport in human kidney.

Philipp Schlatter1, Heike Gutmann, Juergen Drewe.   

Abstract

BACKGROUND: Kidney proximal tubular cells play a major role in the transport of endogenous and exogenous compounds. A multitude of different transporters are expressed starting with multidrug ABC transporters (e.g. abcb1, abcc1-6), slc22a6-8 (organic anion transporters) and slc22a1-3 (organic cation transporters). For transport studies of renal drug transport, cell lines like MDCK and LLC-PK1 are often used to overexpress and study one or two transporters, such as abcb1 or abcc1-6. However, the use is limited since under physiological conditions xenobiotics are transported through different transporters at the same time. Therefore, a primary in vitro model expressing functionally different transporters simultaneously, as it is the case in vivo, would be of great benefit.
METHODS: Primary proximal tubular cells were isolated from porcine kidney. Cells were cultured under selective culturing conditions leading to specific growth of primary proximal tubular cells. Expression of important proximal transporters was checked at mRNA level with RT-PCR, at protein level with immunocytochemistry and functionally by transport and uptake assays.
RESULTS: A model of primary proximal tubular cells was established expressing the most important transporters: abcb1, abcc1, abcc2, slc22a8, slco1a2, slc15a1, slc5a2 and slc4a4. In freshly isolated cells, slc22a1 and slc22a6 were expressed, but were down-regulated in culture. Abcb1, abcc1, abcc2 and slc4a4 were detected at protein level with immunostaining. Functional activity was confirmed for abcb1, abcc1/2, slc22a8, slc15a1/2 and slc5a1/2. The tightness of the monolayers of this model was better than in previously established in vitro models.
CONCLUSION: This primary cell culture model might be an interesting tool to investigate proximal tubular transport and to predict toxicity and drug interactions since it expresses functionally several transporters simultaneously.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16510270     DOI: 10.1016/j.ejps.2006.01.009

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  6 in total

1.  A fluorescence method for measurement of glucose transport in kidney cells.

Authors:  Amy B Blodgett; Rajendra K Kothinti; Ivan Kamyshko; David H Petering; Suresh Kumar; Niloofar M Tabatabai
Journal:  Diabetes Technol Ther       Date:  2011-04-21       Impact factor: 6.118

2.  Tenofovir Disoproxil Fumarate Is a New Substrate of ATP-Binding Cassette Subfamily C Member 11.

Authors:  Wisith Tun-Yhong; Chatchai Chinpaisal; Perayot Pamonsinlapatham; Sindchai Kaewkitichai
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

3.  Purinergic signaling in the lumen of a normal nephron and in remodeled PKD encapsulated cysts.

Authors:  Michael B Hovater; Dragos Olteanu; Elisabeth A Welty; Erik M Schwiebert
Journal:  Purinergic Signal       Date:  2008-04-26       Impact factor: 3.765

4.  Isolation and characterization of a primary proximal tubular epithelial cell model from human kidney by CD10/CD13 double labeling.

Authors:  Cynthia Van der Hauwaert; Grégoire Savary; Viviane Gnemmi; François Glowacki; Nicolas Pottier; Audrey Bouillez; Patrice Maboudou; Laurent Zini; Xavier Leroy; Christelle Cauffiez; Michaël Perrais; Sébastien Aubert
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

5.  Prediction of effective drug combinations by chemical interaction, protein interaction and target enrichment of KEGG pathways.

Authors:  Lei Chen; Bi-Qing Li; Ming-Yue Zheng; Jian Zhang; Kai-Yan Feng; Yu-Dong Cai
Journal:  Biomed Res Int       Date:  2013-09-05       Impact factor: 3.411

6.  Primary porcine proximal tubular cells as an alternative to human primary renal cells in vitro: an initial characterization.

Authors:  Alexandra H Heussner; Daniel R Dietrich
Journal:  BMC Cell Biol       Date:  2013-12-05       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.